La protéine à l’origine de la maladie de Huntington impliquée dans les tumeurs mammaires

These contents could be interesting :

Major Breakthrough in the Treatment of Parkinson’s Disease: A Neuroprosthesis Restores Fluid Walking

Neuroscientists from Inserm, CNRS and Université de Bordeaux in France, along with Swiss researchers and neurosurgeons (EPFL/CHUV/UNIL), have designed and tested a "neuroprosthesis" to correct the gait disorders associated....

A neural organoid with an immune environment

French, Singaporean and British researchers, led by Prof. Florent Ginhoux, head of a research team at Gustave Roussy/Inserm, have succeeded in demonstrating in a neuronal organoid the role of....

Sources

The Huntington disease protein accelerates breast tumor development and metastasis through ErbB2/HER2 signaling.C. Moreira Sousa^1,2,3, J.R. McGuire^1,2,3, M.S. Thion^1,2,3, D. Gentien^1,4, P. de la Grange⁵, S. Tezenas du Montcel^6,7, A. Vincent-Salomon^1,8,9, A. Durr^10,11,12,13, S. Humbert^1,2,3¹Institut Curie, ²CNRS UMR 3306, ³INSERM U1005, ⁴Department of Translational Research, ⁵GenoSplice technology, Institut Universitaire d'hématologie, ⁶AP-HP, Hôpital de la Salpêtrière, Charles-Foix Clinical Research Unit, Department of Biostatistics and Medical Informatics, ⁷ER4, Modelling in Clinical Research, UPMC, ⁸Department of Pathology, ⁹INSERM U830, , ¹⁰UPMC, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, UMR-S975, ¹¹INSERM U975, ¹²CNRS UMR 7225, ¹³AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, EMBO Molecular Medicine, 9 janvier 2013, publication en ligne :